| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |